Statins as adjunct therapy in COPD: is it time to target innate immunity and cardiovascular risk? Young RP, Scott RJ. Eur Respir J 2021;58.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Young RP, Scott RJ. Statins as adjunct therapy in COPD: is it time to target innate immunity and cardiovascular risk? Eur Respir J 2021;58.
PMID: 34326175